LexDanaLexDanabeta
Inventor

Kevin M. Mullane

Inventor
Del Mar, CA, US

Overview

5→
Patents
1995–1999
Patent span
Human necessities
Primary field (CPC A)

Patents· 5 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes44%
C07HSugars22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations11%
C07DHeterocyclic compounds11%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests11%
PatentTitleYear
5,864,033'Adenosine kinase inhibitors'19995,817,640'Methods of preventing tissue damage associated with decreased blood flow by administration of AICA riboside compounds'19985,777,100'AICA riboside analogs'19985,573,772'Methods for protecting tissues and organs from ischemic damage'19965,443,836'Methods for protecting tissues and organs from ischemic damage'1995

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1995–1998Patents assigned to GENSIA INC (3)· patent assignee history
1995–1996Patents assigned to UNIV SOUTH ALABAMA (2)· patent assignee history
1995–1999Based in Del Mar, CA, US· patent location history
1998Patents assigned to GENSIA PHARMA (1)· patent assignee history
1999Patents assigned to METABASIS THERAPEUTICS INC (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GENSIA INC31995–1998
UNIV SOUTH ALABAMA21995–1996
GENSIA PHARMA11998
METABASIS THERAPEUTICS INC11999
Locations
LocationPatentsSpan
Del Mar, California, US51995–1999